MODERN TECHNOLOGIES FOR DIFFERENTIAL DIAGNOSIS OF LARGE B-CELL LYMPHOMAS

Authors

  • Burkhonova Mukhlisa Olim Kizi Author
  • Inogamova Munira Bakhodirovna Author

Keywords:

Key words: Diffuse large B-cell lymphoma (DLBCL); Immunohistochemistry (IHC); Molecular profiling; Flow cytometry; PET/CT, imaging; Artificial intelligence; Differential diagnosis; WHO classification; Biomarkers; Precision oncology.

Abstract

Annotation: Large B-cell lymphomas (LBCLs) are a heterogeneous group of 
non-Hodgkin lymphomas that originate from B-lymphocytes and exhibit diverse 
clinical,  morphological,  and  molecular  characteristics.  Accurate  differential 
diagnosis  of  LBCL  subtypes  often  exceeds  the  capabilities  of  conventional 
histopathological  methods  alone.  Therefore,  modern  diagnostic  technologies  — 
including immunohistochemistry, flow cytometry, molecular and genetic profiling, 
advanced imaging techniques (such as PET/CT), and artificial intelligence-based 
algorithms are increasingly being utilized in clinical practice. This article reviews 
the  role,  applications,  and  advantages  of  these  contemporary  approaches  in 
improving  the  precision  of  differential  diagnosis  in  large  B-cell  lymphomas, 
supported by the latest scientific literature. 

References

1. Verywell Health. Types of B-Cell Lymphoma. 2019. URL:

https://www.verywellhealth.com/types-of-b-cell-lymphoma-4688476 (murojaat

qilingan sana: 13.04.2025).

2. Cottereau A-S, Nioche C, Dirand A-S, Clerc J, Morschhauser F,

Casasnovas O, Meignan M, Buvat I. 18F-FDG-PET dissemination features in

diffuse large B cell lymphoma are predictive of outcome. arxiv. 2020.

arXiv:2012.14179. URL: https://arxiv.org/abs/2012.14179

3. Ta R, Yang D, Hirt C, Drago T, Flavin R. Molecular Diagnostic Review of

Diffuse Large B-Cell Lymphoma and Its Tumor Microenvironment. Diagnostics.

2022;12(5):1087. doi:10.3390/diagnostics12051087

4. Stuckey R, Luzardo Henríquez H, de la Nuez Melian H, Rivero Vera JC,

Bilbao-Sieyro C, Gómez-Casares MT. Integration of molecular testing for the

personalized management of patients with diffuse large B-cell lymphoma and

follicular lymphoma. World Journal of Clinical Oncology. 2023;14(4):160–170.

doi:10.5306/wjco.v14.i4.160

5. Huang H, Qiu L, Yang S, Li L, Nan J, Li Y, Han C, Zhu F, Zhao C, Zhou

W. 3D Lymphoma Segmentation on PET/CT Images via Multi-Scale Information

Fusion with Cross-Attention. arxiv. 2024. arxiv:2402.02349. URL:

https://arxiv.org/abs/2402.02349

Published

2025-05-19

How to Cite

Burkhonova Mukhlisa Olim Kizi, & Inogamova Munira Bakhodirovna. (2025). MODERN TECHNOLOGIES FOR DIFFERENTIAL DIAGNOSIS OF LARGE B-CELL LYMPHOMAS . KONFERENSIYALAR, 1(1), 503-508. https://scientific-jl.com/conf/article/view/16129